相关实验视频
Updated: May 11, 2026

11:11
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
释放ctDNA在肉瘤中的潜力:对最近进展的回顾
Sahana Aiyer1, Tae-Hee Kim1, Katharine Collier2
1College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Cancers
|March 28, 2025
概括
循环瘤DNA (ctDNA) 为软组织肉瘤 (STSs) 提供了一种微创方法. 本综述探讨了ctDNA的应用,突出了其在补充传统基因组分析以改善肉瘤检测和治疗方面的潜力.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 软组织肉瘤 (STSs) 是各种各样的瘤,具有不同的遗传特征.
- 准确的STS分类和检测对于有效的治疗至关重要.
- 目前的基因组分析很大程度上依赖于侵入性组织活检.
研究的目的:
- 审查循环瘤DNA (ctDNA) 在软组织肉瘤 (STSs) 的当前应用.
- 探索ctDNA分析的潜力,作为一种非侵入性工具,用于瘤分析.
- 评估ctDNA分析与STS中已建立的综合基因组分析 (CGP) 的一致性.
主要方法:
- 对STS中的ctDNA分析现有文献的综述.
- 讨论无细胞DNA (cfDNA) 测序技术,包括全基因组和全外基因组测序.
- 基于ctDNA和组织活检的基因组分析的比较分析.
主要成果:
- ctDNA分析提供了一种最少的侵入性方法,用于STSs中的瘤概况.
- ctDNA平台为传统组织活检提供了一个有希望的替代方案.
- 在STS中ctDNA和CGP之间的一致性需要进一步的表征.
结论:
- ctDNA具有革命性的潜力,可以彻底改变肉瘤的分类,检测和治疗监测.
- 需要进一步的研究,以充分利用超低通量全基因组测序和cfDNA的全外体测序在肉瘤患者.
- ctDNA分析可以补充现有的STS诊断和治疗策略.
相关概念视频
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

